Search results
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks via Yahoo Finance· 19 hours agoMerck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Data-Based Insights About Merck & Co Inc
Stocks Register· 1 day agoMerck & Co Inc (NYSE:MRK) price on Thursday, May 09, rose 0.08% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $129.66. A look ...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 21 hours agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
Merck treatment for a type of uterus cancer fails trial
Reuters via Yahoo Finance· 21 hours agoMay 9 (Reuters) - Merck said on Thursday its treatment for a type of uterus cancer did not meet the main goal of disease-free survival in a late-stage trial. (Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
Merck Study of Keytruda With Chemotherapy in Endometrial Cancer Fails to Meet Endpoint
Market Watch· 20 hours agoMerck was hit with a setback in its efforts to expand its blockbuster cancer immunotherapy Keytruda after a late-stage study of its use in combination with chemotherapy to ...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 4 days agoAmong the best stocks to watch, Dow Jones drug giant Merck, Nvidia, Chipotle Mexican Grill and NXP...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 2 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoPRESS RELEASE - 06/05/2024, 07:00 CEST Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region ...
Michael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks By Investing.com
Investing.com· 7 days agoMichael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 4 days agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
